Date | Insider | Price | Amount |
---|---|---|---|
8-11-2020 Insider Buy |
Robert E. Abernathy Director |
$80.93 CAGR » |
$323,720.00 4,000 shares |
8-4-2016 Insider Buy |
Christopher Simon, President & CEO |
$35.00 CAGR » |
$2,099,754.00 60,000 shares |
4-30-2013 Insider Buy |
Peter M. Allen President, Global Plasma |
$32.73 CAGR » |
$14,758.98 451 shares |
4-30-2013 Insider Buy |
Dave Helsel EVP, Global Manufacturing |
$32.73 CAGR » |
$8,901.20 272 shares |
4-30-2013 Insider Buy |
Sandra Jesse Chief Legal Officer |
$32.73 CAGR » |
$20,093.15 614 shares |
4-30-2013 Insider Buy |
Jonathan White Chief Scientific and Technogy |
$32.73 CAGR » |
$20,125.88 615 shares |
4-30-2013 Insider Buy |
Christopher J. Lindop CFO & EVP Business Development |
$32.73 CAGR » |
$13,482.70 412 shares |
4-30-2013 Insider Buy |
Susan M. Hanlon VP Finance |
$32.73 CAGR » |
$8,017.62 245 shares |
4-30-2013 Insider Buy |
Joseph J. Forish VP, Human Resources |
$32.73 CAGR » |
$20,125.88 615 shares |
11-1-2012 Insider Buy |
Peter M. Allen President, Global Plasma |
$61.45 CAGR » |
$6,944.41 113 shares |
11-1-2012 Insider Buy |
Susan M. Hanlon VP Finance |
$61.45 CAGR » |
$7,313.15 119 shares |
11-1-2012 Insider Buy |
Dave Helsel VP, Global Manufacturing |
$61.45 CAGR » |
$8,849.52 144 shares |
11-1-2012 Insider Buy |
Sandra Jesse VP & CLO |
$61.45 CAGR » |
$17,514.67 285 shares |
11-1-2012 Insider Buy |
Christopher J. Lindop CFO & Vice President of |
$61.45 CAGR » |
$8,112.06 132 shares |
5-1-2012 Insider Buy |
Christopher J. Lindop CFO & VP, Business Dev. |
$49.83 CAGR » |
$13,154.33 264 shares |
5-1-2012 Insider Buy |
Peter M. Allen President, Global Plasma |
$49.83 CAGR » |
$14,350.18 288 shares |
5-1-2012 Insider Buy |
Susan M. Hanlon VP Finance |
$49.83 CAGR » |
$7,175.09 144 shares |
5-1-2012 Insider Buy |
Sandra Jesse VP & CLO |
$49.83 CAGR » |
$24,963.33 501 shares |
5-1-2012 Insider Buy |
Jonathan White VP Research and Development |
$49.83 CAGR » |
$21,226.30 426 shares |
5-1-2012 Insider Buy |
Joseph J. Forish VP, Human Resources |
$49.83 CAGR » |
$21,226.30 426 shares |
11-4-2011 Insider Buy |
Christopher J. Lindop CFO & Vice President of |
$51.81 CAGR » |
$11,242.23 217 shares |
11-3-2011 Insider Buy |
Susan M. Hanlon VP Finance |
$51.81 CAGR » |
$7,097.63 137 shares |
11-3-2011 Insider Buy |
Mikael Gordon President, Haemonetics Europe |
$51.81 CAGR » |
$11,812.11 228 shares |
11-4-2011 Insider Buy |
Peter M. Allen Chief Marketing Officer |
$51.81 CAGR » |
$10,516.92 203 shares |
Also See: Institutional Holders of HAE
Also See: SEC filings
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 08/12/2020 | |
End date: | 04/18/2024 | |
Start price/share: | $79.97 | |
End price/share: | $83.46 | |
Dividends collected/share: | $0.00 | |
Total return: | 4.36% | |
Average Annual Total Return: | 1.17% | |
Starting investment: | $10,000.00 | |
Ending investment: | $10,437.95 | |
Years: | 3.68 |
HAE Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent HAE insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding HAE
Free HAE Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |